NPI: 1295189090 · BRONX, NY 10455 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/18/2016
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/18/2016 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,893 | $85K |
| 2019 | 7,050 | $378K |
| 2020 | 15,512 | $791K |
| 2021 | 18,688 | $1.21M |
| 2022 | 24,692 | $1.52M |
| 2023 | 18,003 | $1.51M |
| 2024 | 12,471 | $1.19M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,120 | 2,474 | $4.21M |
| A4657 | Syringe, with or without needle, each | 48,130 | 3,014 | $2.26M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,658 | 1,025 | $137K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 223 | 104 | $29K |
| J1756 | Injection, iron sucrose, 1 mg | 2,859 | 613 | $17K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 918 | 360 | $14K |
| 82728 | 1,337 | 162 | $12K | |
| 82108 | 154 | 13 | $225.18 | |
| 90674 | 13 | 13 | $140.01 | |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $108.39 |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,884 | 480 | $57.13 |